Skip to main content

Find Clinical Trials

Home
Conditions
Stage IIIC Breast Cancer

Clinical trial condition

Stage IIIC Breast Cancer

Explore clinical trials studying Stage IIIC Breast Cancer. Study availability and eligibility vary by location and protocol.

96 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IIIC Breast Cancer trial results

Completed

Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

NCT00118157

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +11 more
Locations: Harper University Hospital - DMC Detroit, Michigan, United States

Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

NCT00407888

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +12 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer

NCT00416715

Conditions: Arthralgia, Breast Diseases, Breast Neoplasms, +17 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

NCT01982591

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +19 more
Locations: Paoli Memorial Hospital Paoli, Pennsylvania, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery

NCT01816035

Conditions: Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +8 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

NCT00795769

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +202 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

NCT00408681

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

NCT00572728

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +7 more
Locations: Scottsdale Medical Imaging Limited Scottsdale, Arizona, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Morton Plant Hospital Clearwater, Florida, United States

View all 27 locations

View Trial Details

Completed

Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer

NCT00070057

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +8 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

NCT01522820

Conditions: Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details